Clinical Trials Browser

Hormone Refractory Prostate Cancer × Everolimus × Clear all

NCT00629525 2015-03-03

RAD001 in Patients With Metastatic, Hormone-Refractory Prostate Cancer

Phase 2 Completed

35 enrolled 6 charts

Hormone Refractory Prostate Cancer